Michael Mullan Alzheimers Research

 

The Roskamp Institute is devoted to understanding causes of and finding cures for neuropsychiatric and neurodegenerative disorders and addictions. Based in Sarasota, Florida, the Institute utilizes a broad range of scientific approaches to understanding the causes of and potential therapies for these disorders with an emphasis on Alzheimer’s disease.

Headed by Dr. Michael Mullan, the institute employs experienced and interdisciplinary scientists and technicians and houses state-of-the-art research labs and equipment to conduct scientific research. The quality of research performed at the institute reflects its motto: “Better science. Real discovery.”

 

Michael Mullan is a biomedical researcher of the β-amyloid protein and its relation to Alzheimer’s disease. Mullan’s Alzheimer research is well known among Biomedical Community. Dr. Mullan Alzheimer research work resulted in identifying the most widely known Swiss Mutation that is present in familial form. Transgenic Animal for Alzheimer Disease uses Swiss Mutation.

Dr. Mullan is currently the director[1] of the Roskamp Institute in Sarasota, Florida. Under Dr. Mullan’s guidelines the institute is carrying out cutting edge research in Alzheimer’s, Traumatic Brain Research, Gulf War Illness and other neuropsychiatric disorder.

 

Please visit websites to learn about Dr. Mullan Alzheimer’s Research Website:

 

 

Recent Posts

Can an Epilepsy Drug Be the Answer to Preventing Alzheimer’s Dementia?

An exciting research study has concluded at Johns Hopkins University and the results could be great news for the millions of patients who suffer from Alzheimer’s dementia.

Epilepsy is a common neurological disorder that affects more than 50 million people in the world. A new drug, antiepileptic levetiracetam, has proved to be successful in reducing seizure activity in epilepsy patients. The drug works to calm hyperactivity in the brain. This hyperactivity is also present in patients with amnestic mild cognitive impairment (aMCI), an early stage of dementia where the patient begins to forget bits of information, such as conversations, appointments and recent activities. It is a mild cognitive impairment and may escape detection, but patients with aMCI are at increased risk for developing Alzheimer’s dementia. According the study, published recently in NeuroImage: Clinical, antiepileptic levetiracetam, when administered in low doses, reduces hyperactivity and improves the performance of such tasks as forming new memories of recent experiences and memory tasks that reside in the hippocampus. This region of the brain is among the first to suffer damage in Alzheimer’s patients.

The John Hopkins researchers conducted a double-blind random test on 84 subjects. The majority of the group had some symptoms of memory dementia, with only 17 control subjects. Various doses of antiepileptic levetiracetam was administered, as well as a placebo. The test results were encouraging. Low doses of the drug resulted in stabilizing hyperactivity and improving memory performance.

Next steps for the John Hopkins research team, according to Michela Gallagher, the lead researcher, is to determine if the results will continue over the long-term, preventing further deterioration of cognitive function or even better, slow-down or block completely advancement to Alzheimer’s dementia. If the drug proves to be effective, it will be tremendously good news for the roughly 5.3 million Americans suffering from Alzheimer’s.

  1. Newly Discovered Control Switch Key to Saving Cells from Untimely Death Comments Off on Newly Discovered Control Switch Key to Saving Cells from Untimely Death
  2. Treating Alzheimer’s disease: A New Chemical Approach Comments Off on Treating Alzheimer’s disease: A New Chemical Approach
  3. Alzheimer’s disease: Molecular Chain Reaction Found? Comments Off on Alzheimer’s disease: Molecular Chain Reaction Found?
  4. Children of Long-lived Parents: Less Risk of Cancer? Comments Off on Children of Long-lived Parents: Less Risk of Cancer?
  5. Alzheimer’s in Mice: Drug-reversible? Comments Off on Alzheimer’s in Mice: Drug-reversible?
  6. Triumphs in Genetic Sequencing of Human Diseases Comments Off on Triumphs in Genetic Sequencing of Human Diseases
  7. Linked: Can Skin Cancer Lower Risk of Alzheimer’s disease? Comments Off on Linked: Can Skin Cancer Lower Risk of Alzheimer’s disease?
  8. A Promising New Alzheimer’s Drug Stops Memory Loss Comments Off on A Promising New Alzheimer’s Drug Stops Memory Loss
  9. Antibodies Effectively Treat Alzheimer’s-like Disease Comments Off on Antibodies Effectively Treat Alzheimer’s-like Disease
  10. ACE Inhibitors and Alzheimer’s Prevention Comments Off on ACE Inhibitors and Alzheimer’s Prevention
  11. Investigational Therapy Focuses on Slowing Progression in Mild and Moderate Comments Off on Investigational Therapy Focuses on Slowing Progression in Mild and Moderate
  12. A Vicious Cycle of Alzheimer’s and Diabetic Hypoglicemia? Comments Off on A Vicious Cycle of Alzheimer’s and Diabetic Hypoglicemia?
  13. A New Drug Reverses Lost Brain Connections in Alzheimer’s Disease Comments Off on A New Drug Reverses Lost Brain Connections in Alzheimer’s Disease
  14. Green Tea May Help Prevent Alzheimer’s Disease Comments Off on Green Tea May Help Prevent Alzheimer’s Disease
  15. Alzheimer’s Disease Progression Halted Due to Increased Protein Expression Comments Off on Alzheimer’s Disease Progression Halted Due to Increased Protein Expression
  16. Stem Cells Used to Grow New Neurons, Brain Repair Circuit Identified Comments Off on Stem Cells Used to Grow New Neurons, Brain Repair Circuit Identified
  17. The Effects of Parkinson’s disease Mutations Reversed within Cells Comments Off on The Effects of Parkinson’s disease Mutations Reversed within Cells
  18. A New Study Shows Small-molecule Drug through Blood-Brain Barrier Comments Off on A New Study Shows Small-molecule Drug through Blood-Brain Barrier
  19. Antidepressant May Slow Progression of Alzheimer’s Disease Comments Off on Antidepressant May Slow Progression of Alzheimer’s Disease
  20. Amino Acids Improve Sleep in Mice with Traumatic Brain Injury Comments Off on Amino Acids Improve Sleep in Mice with Traumatic Brain Injury
  21. Controlling length of mitochondria may cure Alzheimer’s diseases Comments Off on Controlling length of mitochondria may cure Alzheimer’s diseases
  22. Biomarker Could Aid in Revealing Alzheimer’s Early Comments Off on Biomarker Could Aid in Revealing Alzheimer’s Early
  23. Michael Mullan: Brain Fitness Programs – a scam ? Comments Off on Michael Mullan: Brain Fitness Programs – a scam ?
  24. Dr. Michael Mullan Article Published in Herald Tribune: Dr. Michael Mullan: Volunteer to help fight Alzheimer’s Comments Off on Dr. Michael Mullan Article Published in Herald Tribune: Dr. Michael Mullan: Volunteer to help fight Alzheimer’s
  25. Donation Campaign – 36 hour giving challenge campaign Comments Off on Donation Campaign – 36 hour giving challenge campaign
  26. Anti-Tumoral Activity of a Short Decapeptide Fragment of the Alzheimer’s Abeta Peptide. Comments Off on Anti-Tumoral Activity of a Short Decapeptide Fragment of the Alzheimer’s Abeta Peptide.
  27. Impaired orthotopic glioma growth and vascularization in transgenic mouse models of Alzheimer’s disease. Comments Off on Impaired orthotopic glioma growth and vascularization in transgenic mouse models of Alzheimer’s disease.
  28. Characterization and use of human brain microvascular endothelial cells to examine β-amyloid exchange in the blood-brain barrier. Bachmeier C, Mullan M, Paris D. Comments Off on Characterization and use of human brain microvascular endothelial cells to examine β-amyloid exchange in the blood-brain barrier. Bachmeier C, Mullan M, Paris D.
  29. Depletion of CXCR2 inhibits γ-secretase activity and amyloid-β production in a murine model of Alzheimer’s disease. Comments Off on Depletion of CXCR2 inhibits γ-secretase activity and amyloid-β production in a murine model of Alzheimer’s disease.
  30. Selective antihypertensive dihydropyridines lower Aβ accumulation by targeting both the production and the clearance of Aβ across the blood-brain barrier. Comments Off on Selective antihypertensive dihydropyridines lower Aβ accumulation by targeting both the production and the clearance of Aβ across the blood-brain barrier.
  31. Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine. Comments Off on Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine.
  32. Selective dihydropyiridine compounds facilitate the clearance of β-amyloid across the blood-brain barrier. Comments Off on Selective dihydropyiridine compounds facilitate the clearance of β-amyloid across the blood-brain barrier.
  33. Feasibility of Predicting MCI/AD Using Neuropsychological Tests and Serum β-Amyloid. Comments Off on Feasibility of Predicting MCI/AD Using Neuropsychological Tests and Serum β-Amyloid.
  34. Flavonoids lower Alzheimer’s Aβ production via an NFκB dependent mechanism. Comments Off on Flavonoids lower Alzheimer’s Aβ production via an NFκB dependent mechanism.
  35. Roskamp Institute in Sarasota, Florida, have shown that an anatabine compound supplied by Rock Creek has beneficial effects on memory and learning in animal models of Alzheimer’s Disease. Michael Mullan, MD, Ph.D., CEO of the Roskamp Institute and his colleague, Dr. Daniel Paris, published these findings in October, 2011 in the European Journal of Pharmacology Comments Off on Roskamp Institute in Sarasota, Florida, have shown that an anatabine compound supplied by Rock Creek has beneficial effects on memory and learning in animal models of Alzheimer’s Disease. Michael Mullan, MD, Ph.D., CEO of the Roskamp Institute and his colleague, Dr. Daniel Paris, published these findings in October, 2011 in the European Journal of Pharmacology
  36. Mike Mullan Alzheimer Researcher Comments on: Nicotine May Help Combat Memory Loss study by Dr. Newhouse Comments Off on Mike Mullan Alzheimer Researcher Comments on: Nicotine May Help Combat Memory Loss study by Dr. Newhouse
  37. Identification of Plasma Biomarkers of TBI Outcome Using Proteomic Approaches in an APOE Mouse Model. Comments Off on Identification of Plasma Biomarkers of TBI Outcome Using Proteomic Approaches in an APOE Mouse Model.
  38. Anatabine lowers Alzheimer’s Aβ production in vitro and in vivo Comments Off on Anatabine lowers Alzheimer’s Aβ production in vitro and in vivo
  39. Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer’s disease. Comments Off on Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer’s disease.
  40. Genetic deletion of TNF receptor suppresses excitatory synaptic transmission via reducing AMPA receptor synaptic localization in cortical neurons. Comments Off on Genetic deletion of TNF receptor suppresses excitatory synaptic transmission via reducing AMPA receptor synaptic localization in cortical neurons.
  41. Proteomic CNS profile of delayed cognitive impairment in mice exposed to gulf war agents. Comments Off on Proteomic CNS profile of delayed cognitive impairment in mice exposed to gulf war agents.
  42. Institute targets in on Alzheimer’s Comments Off on Institute targets in on Alzheimer’s
  43. Sarasota’s Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes Comments Off on Sarasota’s Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
  44. The Roskamp Institute Comments Off on The Roskamp Institute
  45. Roskamp Institute on Gulf War Illness Comments Off on Roskamp Institute on Gulf War Illness
  46. The Roskamp Institute Battles Drug Abuse Comments Off on The Roskamp Institute Battles Drug Abuse
  47. The Traumatic Brain Injury Program at the Roskamp Institute Comments Off on The Traumatic Brain Injury Program at the Roskamp Institute
  48. Roskamp Institute finds one of the genetic causes for Tourettes syndrome Comments Off on Roskamp Institute finds one of the genetic causes for Tourettes syndrome
  49. Sarasota’s Roskamp Institute Welcomes U.S. Senator Bill Nelson Comments Off on Sarasota’s Roskamp Institute Welcomes U.S. Senator Bill Nelson
  50. Dr. Mullan’s Alzheimer Research Offers Invaluable Insights On The Disease Comments Off on Dr. Mullan’s Alzheimer Research Offers Invaluable Insights On The Disease
  51. Dr. Mullan’s Alzheimer Research Identified Various Genetic Variations Comments Off on Dr. Mullan’s Alzheimer Research Identified Various Genetic Variations
  52. Family History of Alzheimer’s disease – what does it mean? Comments Off on Family History of Alzheimer’s disease – what does it mean?
  53. ß-amyloid exchage in the blood-brain barrier Comments Off on ß-amyloid exchage in the blood-brain barrier
  54. Why work with Alzheimer’s disease patients? Comments Off on Why work with Alzheimer’s disease patients?
  55. Alzheimer’s disease drug developed at Roskamp Institute approved for key clinical trial funding in Europe Comments Off on Alzheimer’s disease drug developed at Roskamp Institute approved for key clinical trial funding in Europe
  56. Roskamp institute studies may lead to better diagnosis Comments Off on Roskamp institute studies may lead to better diagnosis
  57. Research Highlights The Direct Causes Related To The Disease Comments Off on Research Highlights The Direct Causes Related To The Disease
  58. Dr. Mullan’s Alzheimer Research Involved Studying Brain Proteins Comments Off on Dr. Mullan’s Alzheimer Research Involved Studying Brain Proteins
  59. Roskamp Institute researchers show that some antibodies but, not others may be helpful in removing the Alzheimer amyloid from the brain of Alzheimer’s sufferers. Comments Off on Roskamp Institute researchers show that some antibodies but, not others may be helpful in removing the Alzheimer amyloid from the brain of Alzheimer’s sufferers.
  60. Mullan Alzheimer Research Institute Roskamp Institute aids high school students in genetic research Comments Off on Mullan Alzheimer Research Institute Roskamp Institute aids high school students in genetic research
  61. The Roskamp Institute investigates the role of anatabine in lowering Alzheimer’s Abeta levels. Comments Off on The Roskamp Institute investigates the role of anatabine in lowering Alzheimer’s Abeta levels.
  62. Alzheimer Research Institute Headed By Dr. Michael Mullan Featured in the Sarasota Herald Tribune : Roskamp Institute research could help veterans Comments Off on Alzheimer Research Institute Headed By Dr. Michael Mullan Featured in the Sarasota Herald Tribune : Roskamp Institute research could help veterans
  63. Dr. Mullan Alzheimer Presentation at Pines of Sarasota Comments Off on Dr. Mullan Alzheimer Presentation at Pines of Sarasota
  64. Roskamp Institute Celebrated Veterans Day with a seminar by Alzheimer Researcher Dr. Michael Mullan Comments Off on Roskamp Institute Celebrated Veterans Day with a seminar by Alzheimer Researcher Dr. Michael Mullan
  65. Alzheimer Expert Dr. Mullan’s comments on CD40L induces Abeta production via signaling by the granulocyte macrophage colony stimulating factor (GM-CSF) Comments Off on Alzheimer Expert Dr. Mullan’s comments on CD40L induces Abeta production via signaling by the granulocyte macrophage colony stimulating factor (GM-CSF)
  66. Alzheimer Researcher Dr. Michael Mullans Note on Potent anti-angiogenic motifs within the Alzheimer beta-amyloid peptide. Comments Off on Alzheimer Researcher Dr. Michael Mullans Note on Potent anti-angiogenic motifs within the Alzheimer beta-amyloid peptide.
  67. Effect of NSAIDS on cognitive ability of Alzheimer’s Patient — Comment by Alzheimer Researcher Mullan Comments Off on Effect of NSAIDS on cognitive ability of Alzheimer’s Patient — Comment by Alzheimer Researcher Mullan
  68. Dr. Mullan’s Alzheimer Research Notes on NSAIDS and their effect on Alzheimers disease Comments Off on Dr. Mullan’s Alzheimer Research Notes on NSAIDS and their effect on Alzheimers disease
  69. Roskamp Institute Gulf War Illness research program Comments Off on Roskamp Institute Gulf War Illness research program
  70. Event: Journal Club “Disrupted-in-Schizophrenia-1 expression is regulated by β-site amyloid precursor protein cleaving enzyme-1–neuregulin cascade” Comments Off on Event: Journal Club “Disrupted-in-Schizophrenia-1 expression is regulated by β-site amyloid precursor protein cleaving enzyme-1–neuregulin cascade”
  71. Event: Journal Club “The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer’s disease” Comments Off on Event: Journal Club “The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer’s disease”
  72. News:Nomination for Business/Education Partnership Award through the School District of Manatee County’s ePIE program Comments Off on News:Nomination for Business/Education Partnership Award through the School District of Manatee County’s ePIE program
  73. News:Roskamp Institute was recognized by the South East High School Technical Student association for partnering will the in a diabetes project Comments Off on News:Roskamp Institute was recognized by the South East High School Technical Student association for partnering will the in a diabetes project
  74. News: FDA advisory committee unanimously recommends approval of Novartis investigational treatment FTY720 to treat relapsing remitting MS Comments Off on News: FDA advisory committee unanimously recommends approval of Novartis investigational treatment FTY720 to treat relapsing remitting MS
  75. Event: Journal Club “NF-jB activity affects learning in aversive tasks: Possible actions via modulation of the stress axis” Comments Off on Event: Journal Club “NF-jB activity affects learning in aversive tasks: Possible actions via modulation of the stress axis”
  76. News Comments Off on News
  77. APOLIPOPROTEIN E GENOTYPE AND OXIDATIVE STRESS RESPONSE TO TRAUMATIC BRAIN INJURY Comments Off on APOLIPOPROTEIN E GENOTYPE AND OXIDATIVE STRESS RESPONSE TO TRAUMATIC BRAIN INJURY
  78. Event Journal Club:Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer’s disease mice Comments Off on Event Journal Club:Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer’s disease mice
  79. Event: Journal Club Comments Off on Event: Journal Club
  80. Announcement Comments Off on Announcement
  81. News:Dr Crawford will be speaking at 2nd Annual Girls S.T.E.M. Summit Comments Off on News:Dr Crawford will be speaking at 2nd Annual Girls S.T.E.M. Summit
  82. Alzheimer’s beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2 Comments Off on Alzheimer’s beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2
  83. Tech Tips, #2: Making a homemade frit for fused silica columns Comments Off on Tech Tips, #2: Making a homemade frit for fused silica columns
  84. Do You Or Someone You Care For Suffer From Alzheimer’s Disease? Comments Off on Do You Or Someone You Care For Suffer From Alzheimer’s Disease?
  85. Reduction of b-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer’s disease Comments Off on Reduction of b-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer’s disease
  86. NEWS RELEASE:Investigational Immune Intervention Slows Brain Atrophy in Alzheimer’s Patients Comments Off on NEWS RELEASE:Investigational Immune Intervention Slows Brain Atrophy in Alzheimer’s Patients
  87. Journal Club Comments Off on Journal Club
  88. FREE MEMORY SCREENING-Sarasota FL Comments Off on FREE MEMORY SCREENING-Sarasota FL
  89. Anti-Tumoral Activity of a Short Decapeptide Fragment of the Alzheimer’s Abeta Peptide Comments Off on Anti-Tumoral Activity of a Short Decapeptide Fragment of the Alzheimer’s Abeta Peptide
  90. Diagnostic utility of APOE, soluble CD40, CD40L, and Abeta1-40 levels in plasma in Alzheimer’s disease Comments Off on Diagnostic utility of APOE, soluble CD40, CD40L, and Abeta1-40 levels in plasma in Alzheimer’s disease
  91. CD40/CD40L interaction induces Abeta production and increases gamma-secretase activity independently of tumor necrosis factor receptor associated factor (TRAF) signaling. Comments Off on CD40/CD40L interaction induces Abeta production and increases gamma-secretase activity independently of tumor necrosis factor receptor associated factor (TRAF) signaling.
  92. Roskamp Institute Poster Abstract from VA Reasearch Week Comments Off on Roskamp Institute Poster Abstract from VA Reasearch Week
  93. Handling Unstructured Data in Biological Research and Clinical Trials Comments Off on Handling Unstructured Data in Biological Research and Clinical Trials
  94. Tech Tips: Comments Off on Tech Tips:
  95. Roskamp Institute is participating in VA Research Week Activities Comments Off on Roskamp Institute is participating in VA Research Week Activities
  96. Roskamp Institute-LECOM collaboration Comments Off on Roskamp Institute-LECOM collaboration
  97. High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer’s disease patients Comments Off on High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer’s disease patients
  98. Journal Club: The presence of sodium dodecyl sulphate-stable Aβ dimers is strongly associated with Alzheimer-type dementia Comments Off on Journal Club: The presence of sodium dodecyl sulphate-stable Aβ dimers is strongly associated with Alzheimer-type dementia
  99. Alzheimer’s Disease Anti-Inflammatory Prevention Trial Comments Off on Alzheimer’s Disease Anti-Inflammatory Prevention Trial
  100. Roskamp Institute is at Facebook! Comments Off on Roskamp Institute is at Facebook!
  101. Adaptation of the circular platform spatial memory task for mice: use in detecting cognitive impairment in the APPSW transgenic mouse model for Alzheimer’s disease Comments Off on Adaptation of the circular platform spatial memory task for mice: use in detecting cognitive impairment in the APPSW transgenic mouse model for Alzheimer’s disease
  102. Characteristics of thein VitroVasoactivity of β-Amyloid Peptides Comments Off on Characteristics of thein VitroVasoactivity of β-Amyloid Peptides
  103. Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer’s disease Comments Off on Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer’s disease
  104. Cross Validation of the Montreal Cognitive Assessment in Community Dwelling Older Adults Residing in the Southeastern US Comments Off on Cross Validation of the Montreal Cognitive Assessment in Community Dwelling Older Adults Residing in the Southeastern US
  105. Volunteers for early detection of cognitive decline in older adults Comments Off on Volunteers for early detection of cognitive decline in older adults
  106. Roskamp Institute hosted a town hall meeting for the Alzheimer’s Association. Comments Off on Roskamp Institute hosted a town hall meeting for the Alzheimer’s Association.
  107. Roskamp Institute Scientist Awarded a grant from the Alzheimers Association to investigate a novel therapeutic agent for the treatment of Alzheimer’s Disease. Comments Off on Roskamp Institute Scientist Awarded a grant from the Alzheimers Association to investigate a novel therapeutic agent for the treatment of Alzheimer’s Disease.
  108. Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer’s Disease. Comments Off on Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer’s Disease.
  109. Roskamp Institute Announces Enrollment of First Students to Participate in its Innovative Research Doctorate Program Comments Off on Roskamp Institute Announces Enrollment of First Students to Participate in its Innovative Research Doctorate Program
  110. Southeast High School’s Roskamp Institute project placed first in Florida and fifth in National Technology Students Association finals Comments Off on Southeast High School’s Roskamp Institute project placed first in Florida and fifth in National Technology Students Association finals
  111. Local Researchers at Roskamp Institute to Test Investigational Gammaglobulin Treatment for Alzheimer’s Disease Comments Off on Local Researchers at Roskamp Institute to Test Investigational Gammaglobulin Treatment for Alzheimer’s Disease
  112. World Alzheimer’s Day: Leaders Call for Early Diagnosis and Aggressive Research Comments Off on World Alzheimer’s Day: Leaders Call for Early Diagnosis and Aggressive Research
  113. Dementia in Older Women Comments Off on Dementia in Older Women
  114. Alzheimer’s and Blood Pressure Comments Off on Alzheimer’s and Blood Pressure
  115. What do the names of Barack Obama, Hillary Clinton, and John McCain have to do with Alzheimer’s disease? Comments Off on What do the names of Barack Obama, Hillary Clinton, and John McCain have to do with Alzheimer’s disease?
  116. Double Amyloid Causes Memory Loss Comments Off on Double Amyloid Causes Memory Loss
  117. First Critical Clinical Tests of the Amyloid Theory of Alzheimer’s Disease Comments Off on First Critical Clinical Tests of the Amyloid Theory of Alzheimer’s Disease
  118. Elan Vaccine and Alzheimer’s Disease Drug development Comments Off on Elan Vaccine and Alzheimer’s Disease Drug development
  119. Alzheimer’s Disease Drug development Comments Off on Alzheimer’s Disease Drug development
  120. Clinical research for Alzheimer’s Disease at the Roskamp Institute Comments Off on Clinical research for Alzheimer’s Disease at the Roskamp Institute
  121. DRUG ADDICTION RESEARCH AT THE ROSKAMP INSTITUTE Comments Off on DRUG ADDICTION RESEARCH AT THE ROSKAMP INSTITUTE
  122. Traumatic Brain Injury in the War Zone Comments Off on Traumatic Brain Injury in the War Zone
  123. Research On Traumatic Brain Injury At The Roskamp Institute Comments Off on Research On Traumatic Brain Injury At The Roskamp Institute
  124. ABeta as Antiangiogenic drug Comments Off on ABeta as Antiangiogenic drug
  125. Roskamp Institute examines the cellular responses to biological warfare agents Comments Off on Roskamp Institute examines the cellular responses to biological warfare agents
  126. Clinical Trials for Alzheimer’s Disease at the Roskamp Institute Comments Off on Clinical Trials for Alzheimer’s Disease at the Roskamp Institute
  127. Press release for James & Esther King Biomedical Research Program grant Comments Off on Press release for James & Esther King Biomedical Research Program grant
  128. Genetic manipulation of CD40L reduces Tau phosphorylation Comments Off on Genetic manipulation of CD40L reduces Tau phosphorylation
  129. The granulocyte macrophage-colony stimulating factor (GM-CSF) regulates amyloid production Comments Off on The granulocyte macrophage-colony stimulating factor (GM-CSF) regulates amyloid production
  130. Potent antiangiogenic motif in amyloid beta Comments Off on Potent antiangiogenic motif in amyloid beta
  131. CD40L induces Abeta production via signaling by the granulocyte macrophage colony stimulating factor (GM-CSF) Comments Off on CD40L induces Abeta production via signaling by the granulocyte macrophage colony stimulating factor (GM-CSF)
  132. Potent anti-angiogenic motifs within the Alzheimer beta-amyloid peptide Comments Off on Potent anti-angiogenic motifs within the Alzheimer beta-amyloid peptide
  133. Effect of NSAIDS on cognitive ability of Alzheimer’s Patients Comments Off on Effect of NSAIDS on cognitive ability of Alzheimer’s Patients
  134. NSAIDS and their effect on Alzheimers disease Comments Off on NSAIDS and their effect on Alzheimers disease
  135. Roskamp Institute is Part of a Great Technology Cluster Comments Off on Roskamp Institute is Part of a Great Technology Cluster
  136. Roskamp Institute Receives Lung Cancer Research Grant Comments Off on Roskamp Institute Receives Lung Cancer Research Grant
  137. Roskamp Institute Recognized for Its Beautification Efforts Comments Off on Roskamp Institute Recognized for Its Beautification Efforts
  138. Roskamp Institute Helps Florida’s Economy Comments Off on Roskamp Institute Helps Florida’s Economy
  139. Roskamp Institute Supports Moves for Greater State Funding of Biotech Research Comments Off on Roskamp Institute Supports Moves for Greater State Funding of Biotech Research
  140. Roskamp Institute Looking for Alzheimer’s Clinical Trial Participants Comments Off on Roskamp Institute Looking for Alzheimer’s Clinical Trial Participants
  141. The Roskamp Institute Plans Alzheimer’s Treatment Trial Comments Off on The Roskamp Institute Plans Alzheimer’s Treatment Trial
  142. Roskamp’s Fiona Crawford to Participate in Panel Discussion Comments Off on Roskamp’s Fiona Crawford to Participate in Panel Discussion
  143. Roskamp Institute Will Host Neuroscience Doctorate Research Program Comments Off on Roskamp Institute Will Host Neuroscience Doctorate Research Program
  144. Roskamp Institute Alzheimer’s Research Validated by Independent Japanese Study Comments Off on Roskamp Institute Alzheimer’s Research Validated by Independent Japanese Study
  145. Roskamp Institute Receives Award of Appreciation Comments Off on Roskamp Institute Receives Award of Appreciation
  146. Roskamp Institute Studying Potential Usefulness of Beta-amyloid in Treating Alzheimer’s Comments Off on Roskamp Institute Studying Potential Usefulness of Beta-amyloid in Treating Alzheimer’s
  147. Nilvadipine an anti-hypertensive drug, as a potential treatment for Alzheimer’s disease Comments Off on Nilvadipine an anti-hypertensive drug, as a potential treatment for Alzheimer’s disease
  148. Anti-hypertension Drugs and Alzheimers Comments Off on Anti-hypertension Drugs and Alzheimers
  149. Roskamp Institute’s Fiona Crawford to Moderate at Power of Women Series Comments Off on Roskamp Institute’s Fiona Crawford to Moderate at Power of Women Series
  150. Conscientious people are less prone to Alzheimer’s Comments Off on Conscientious people are less prone to Alzheimer’s
  151. The Traumatic Brain Injury Program at the Roskamp Institute Comments Off on The Traumatic Brain Injury Program at the Roskamp Institute
  152. Sarasota’s Roskamp Institute Welcomes U.S. Senator Bill Nelson Comments Off on Sarasota’s Roskamp Institute Welcomes U.S. Senator Bill Nelson
  153. Senator Nelson Visit Roskamp Institute Comments Off on Senator Nelson Visit Roskamp Institute
  154. Roskamp Institute Aims to Help Injured Soldiers Comments Off on Roskamp Institute Aims to Help Injured Soldiers
  155. British Experts Question Need for Baby Scans Comments Off on British Experts Question Need for Baby Scans
  156. Chromosomes Shed New Light on Down Syndrome Comments Off on Chromosomes Shed New Light on Down Syndrome
  157. Down Syndrome Patient Learning New Skills Comments Off on Down Syndrome Patient Learning New Skills
  158. Novartis Required to Correct Advertising Comments Off on Novartis Required to Correct Advertising
  159. Tracking Wandering Alzheimer’s Sufferers Comments Off on Tracking Wandering Alzheimer’s Sufferers
  160. Alzheimer’s Caregiver Training Comments Off on Alzheimer’s Caregiver Training
  161. Attending College with Intellectual Disabilities Comments Off on Attending College with Intellectual Disabilities
  162. National Down Syndrome Society Comments Off on National Down Syndrome Society
  163. Alzheimer’s Widow to Serve as British Government Adviser Comments Off on Alzheimer’s Widow to Serve as British Government Adviser
  164. Alzheimer’s Disease Disscusion Forum Comments Off on Alzheimer’s Disease Disscusion Forum
  165. The Roskamp Institute Is Good for Manatee County, Florida Comments Off on The Roskamp Institute Is Good for Manatee County, Florida
  166. Roskamp Institute Obesity and Diabetes Study Official Release Comments Off on Roskamp Institute Obesity and Diabetes Study Official Release
  167. Roskamp Institute Study Examines Obesity Comments Off on Roskamp Institute Study Examines Obesity
  168. Clinical Trial Information Comments Off on Clinical Trial Information
  169. Sarkozy Vows to Defeat Alzheimer’s Comments Off on Sarkozy Vows to Defeat Alzheimer’s
  170. Study: Spice can help Alzheimer’s Patients Comments Off on Study: Spice can help Alzheimer’s Patients
  171. Want a job in science research? Comments Off on Want a job in science research?
  172. Roskamp Institute Tries to Improve Life of Alzheimer’s Suffers Comments Off on Roskamp Institute Tries to Improve Life of Alzheimer’s Suffers
  173. Neuropsychology Comments Off on Neuropsychology
  174. Study: Alzheimer’s Cases May Quadruple by 2050 Comments Off on Study: Alzheimer’s Cases May Quadruple by 2050
  175. Alzheimer’s Support Groups Comments Off on Alzheimer’s Support Groups
  176. Roskamp Celebrated 2006 World Alzheimer’s Day with Clinical Trial Lauch Comments Off on Roskamp Celebrated 2006 World Alzheimer’s Day with Clinical Trial Lauch
  177. Good News for Alzheimer’s Drug Comments Off on Good News for Alzheimer’s Drug
  178. Roskamp Institute Announces New Treatment Comments Off on Roskamp Institute Announces New Treatment
  179. Roskamp Institute Media Coverage Comments Off on Roskamp Institute Media Coverage
  180. The Roskamp Institute is Participating in a New Phase III MS Study Comments Off on The Roskamp Institute is Participating in a New Phase III MS Study
  181. Michael Mullan Featured in Another Story Comments Off on Michael Mullan Featured in Another Story
  182. Roskamp’s Michael Mullan Interviewed by St. Petersburg Times Comments Off on Roskamp’s Michael Mullan Interviewed by St. Petersburg Times
  183. Sarasota’s Roskamp Institute Announces Participation in Multiple Sclerosis Study Comments Off on Sarasota’s Roskamp Institute Announces Participation in Multiple Sclerosis Study
  184. Roskamp Institute recruiting for clinical trials Comments Off on Roskamp Institute recruiting for clinical trials
  185. Roskamp Institute Announces New Class Of Drugs That Can Impact Alzheimer’s Disease Comments Off on Roskamp Institute Announces New Class Of Drugs That Can Impact Alzheimer’s Disease